54.18
+2.32%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Net income
$2.48bn
FY2016FY2025
Total assets
$17.21bn
FY2016FY2025
Shareholders' equity
$8.90bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | — | — | $1 | $1 | $1 | $0 | — | — | — | — |
| Operating income | $3.03bn | $2.76bn | $2.96bn | $3.05bn | $2.07bn | $1.36bn | $1.36bn | $8.05bn | $5.96bn | $4.58bn |
| Net income | $2.48bn | $2.17bn | $1.84bn | $1.92bn | $1.85bn | $382.0m | $1.91bn | $3.58bn | $1.46bn | $1.65bn |
| Diluted earnings per share | 1.51 | 1.94 | 4.73 | 4.83 | 1.15 | 0.25 | 1.23 | 2.45 | 0.99 | 0.89 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.21bn | $4.39bn | $3.21bn | $3.16bn | $25.64bn | $22.47bn | $323.97bn | $256.28bn | $192.72bn | $159.83bn |
| Cash and short-term investments | $1.58bn | $12.0m | $9.0m | $1.0m | $2.49bn | $2.10bn | $10.38bn | $11.77bn | $7.71bn | $7.53bn |
| Total liabilities | $6.92bn | $1.11bn | $1.12bn | $784.0m | $11.24bn | $10.52bn | $207.12bn | $159.13bn | $112.85bn | $90.14bn |
| Debt | $3.66bn | $229.0m | $261.0m | $3.0m | $4.56bn | $4.78bn | $159.60bn | $120.62bn | $80.64bn | $67.05bn |
| Shareholders' equity | $8.90bn | $3.25bn | $2.08bn | $2.38bn | $14.40bn | $11.95bn | $116.85bn | $97.15bn | $79.87bn | $69.69bn |
| Shares outstanding | 1,647m | 1,119m | 389m | 396m | 1,612m | 1,541m | 1,551m | 1,464m | 1,475m | 1,854m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | $1.33bn | $901.0m | $947.0m | $769.0m | $668.0m | $816.0m | $793.0m | $771.0m |
| Net income | $904.0m | $608.5m | $560.0m | $716.0m | $620.0m | $581.0m | $688.0m | $544.0m |
| Diluted earnings per share | 0.56 | 0.38 | 0.34 | 0.43 | 0.38 | 0.35 | 0.61 | 0.49 |
| Total assets | $20.08bn | $17.94bn | $17.21bn | $16.52bn | $16.14bn | $14.97bn | $4.39bn | $4.32bn |
| Cash and short-term investments | $1.50bn | $1.04bn | $1.58bn | $1.06bn | $480.0m | $332.0m | $12.0m | $16.0m |
| Debt | $8.72bn | $6.76bn | $4.12bn | $2.39bn | $1.76bn | $1.04bn | $219.0m | $210.0m |
| Shareholders' equity | $11.87bn | $7.62bn | $8.90bn | $8.46bn | $8.47bn | $8.49bn | $3.25bn | $3.22bn |
Financial ratios
Data as of 10 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 65.8% | 69.4% | 72.8% | 84.0% | 67.0% | 63.3% |
| Net margin | 53.9% | 54.5% | 45.3% | 52.8% | 60.0% | 17.7% |
| Return on equity | 27.9% | 66.8% | 88.6% | 80.6% | 12.9% | 3.2% |
| Return on assets | 14.4% | 49.4% | 57.4% | 60.6% | 7.2% | 1.7% |
| Revenue growth | 15.8% | -2.0% | 12.0% | 17.5% | 43.3% | -0.9% |
| Earnings growth | 14.6% | 17.9% | -4.0% | 3.5% | 384.6% | -80.0% |
| Current ratio | 4.20x | 0.88x | 0.80x | 1.00x | 0.90x | 1.79x |
| Debt to equity | 0.46x | 0.34x | 0.12x | 0.00x | 12.25x | 12.82x |
| Equity ratio | 51.7% | 74.0% | 64.8% | 75.2% | 56.2% | 53.2% |
| Interest coverage | 26.38x | 20.31x | 41.66x | 1015.33x | 5.41x | 3.62x |
| R&D as a share of sales | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | -47.1% | -188.0% | 1.9% | 75.4% | -4.7% | 0.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.3% | 16.4% | -13.6% |
| Operating income | -0.1% | 17.3% | -1.9% |
| Net income | 9.1% | 45.4% | 0.6% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 67.5% | 72.5% | 70.8% | 23.5% |
| Net margin | 54.2% | 51.6% | 49.4% | 13.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 34.7 | 40.3 | 11.3 | 8.0 |
| Price to sales | 18.7 | 21.9 | 5.1 | 4.2 |
Market value over time
24 Feb 2021 to 9 Sept 2026, in USD
$17.55bn$77.27bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Return | -7% | 49% | 36% | -14% |
Dividends and splits
Per share, in the currency the company pays
Paid for 26 years. Last went ex-dividend on 31 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.506 | 1.75 | 1.52 | 1.28 | 0.56 | 0.52 | 0.48 | 0.427 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.